MiiS Business Summary

Medimaging Integrated Solution Inc. (MiiS) is a leading developer of digital handheld diagnostic imaging solutions, primarily generating revenue through the sale of its proprietary "Horus Scope" product line, high-precision micro camera modules for endoscopy, and OEM/ODM manufacturing services for global medical device firms. The company’s business model is increasingly shifting toward high-margin recurring revenue through AI-integrated diagnostic software-as-a-service (SaaS) and single-use endoscopic consumables. MiiS operates across four primary segments: Digital Medical Imaging (ophthalmology, otology, and dermatology), Endoscopy Solutions, Micro Camera Modules, and AI Intelligent Medical Systems. In the global market, MiiS competes directly with Optomed, Nidek, Carl Zeiss Meditec, and Volk Optical. It distinguishes itself by offering superior portability and integrated AI-driven screening for conditions like diabetic retinopathy, positioning itself as a critical infrastructure provider for the expanding telemedicine and remote primary care sectors. Founded in 2010 and headquartered in the Hsinchu Science Park, MiiS is led by Chairman and CEO Dr. Chu-Ming (Rex) Cheng, an expert in optoelectronics with a Ph.D. in Optical Sciences and a technical pedigree from the Industrial Technology Research Institute (ITRI). The executive leadership team includes General Manager Stefan Cheng, who also serves as the company’s primary spokesman, and Vice President Serean Ko. The company’s board and shareholder base feature significant institutional backing, most notably from Baxter International Inc. and Control Optics Taiwan Inc., reflecting its strategic importance in the global medical imaging supply chain. This leadership team has successfully transitioned MiiS from a hardware-centric manufacturer to an AI-driven medical technology firm, leveraging Taiwan’s advanced semiconductor and optical manufacturing ecosystem to maintain a competitive edge in miniaturized diagnostic hardware.